ANTHRACYCLINE CARDIOTOXICITY IN NON-HODGKIN’S LYMPHOMA MEDIASTINAL MASS: A CASE REPORT
Anthracycline is often used for treatment of hematologic malignancies and solid tumors, and the damage it causes to the heart muscle has long been known; therefore, the cardiac toxicity, one of the treatment-related co-morbidities, has become an issue for cancer survivors. Cardiotoxicity has been...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Associazione Italiana Giovani Medici
2015-04-01
|
Series: | Euromediterranean Biomedical Journal |
Online Access: | http://www.embj.org/images/ISSUE_2015/Natali_4.pdf |